feedback

Course Director

Robert Dreicer, MD, MS, MACP, FASCO
Robert Dreicer, MD, MS, MACP, FASCO

University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

Faculty

Tomasz M. Beer
Tomasz M. Beer, MD

OHSU Knight Cancer Institute
Portland, Oregon

William K. Oh
William K. Oh, MD

Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Evan Y. Yu
Evan Y. Yu, MD

University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Seattle, Washington

Accredited by

Penn State College of Medicine

Activity Details

Credit Types:CME
Credit Amount:1.5 Credits
Release Date:2018-Jul-05
Expiration Date:2019-Jul-04
Registration Required:No
Cost:Free

Activity Description and Educational Objectives

In this activity, based on a recent live symposium at the 2018 Annual Meeting of the American Society of Clinical Oncology, top experts review the latest advances and strategies for personalizing prostate cancer treatment throughout the disease continuum and share their personal experiences from the front lines of research and patient care.

Upon completion of this activity, participants should be better able to:
  • Cite recent data on the efficacy and safety of approved and investigational therapies and novel combinations for prostate cancer, and the clinical implications of these data
  • Describe current and planned clinical trials assessing a variety of agents—including hormone, cytotoxic, immuno-oncology, bone-directed, molecularly targeted, and other novel therapies alone or in combination—in different prostate cancer settings
  • Recommend individualized treatment plans for patients with prostate cancer, incorporating and appropriately sequencing new agents and combinations, while considering clinical guidelines, expert recommendations, disease and patient characteristics, and patient needs/preferences

Target Audience

This activity has been designed to meet the educational needs of oncologists and other healthcare professionals involved in the care of patients with prostate cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: July 05, 2018 - July 04, 2019
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Robert Dreicer, MD, MS, MACP, FASCO
Section Head Medical Oncology
Deputy Director, University of Virginia Cancer Center
Associate Director for Clinical Research
Co-Director, Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, Virginia

Robert Dreicer, MD, MS, MACP, FASCO, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Astellas Pharma US, Inc.; AstraZeneca; Bristol-Myers Squibb; EMD Serono, Inc.; Genentech, Inc.; Incyte Corporation; Orion; and Pfizer Inc.

Faculty

Tomasz M. Beer, MD
Professor of Medicine, Hematology & Medical Oncology
Deputy Director, OHSU Knight Cancer Institute
Portland, Oregon

Tomasz M. Beer, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Janssen Research & Development; Medivation, Inc./Astellas Pharma US, Inc.; OncoGenex Pharmaceuticals; Sotio, LLC; and Theraclone Sciences/OncoResponse, Inc.
Stock Shareholder in Salarius Pharmaceuticals LLC.
Consultant and/or Advisor for AbbVie Inc.; AstraZeneca; Astellas Pharma US, Inc.; Bayer Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Clovis Oncology; Janssen Biotech; Janssen Japan; Merck & Co., Inc.; and Pfizer Inc.

William K. Oh, MD
Chief, Division of Hematology and Medical Oncology
Deputy Director, Tisch Cancer Institute
Professor of Medicine and Urology
Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
New York, New York

William K. Oh, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Amgen Inc.; AstraZeneca; Bayer Corporation; EMD Serono, Inc.; Janssen Pharmaceuticals, Inc.; and sanofi-aventis.

Evan Y. Yu, MD
Professor, Department of Medical Oncology
University of Washington School of Medicine
Medical Director, Clinical Research Support
Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Evan Y. Yu, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Bayer Corporation; Dendreon Pharmaceuticals LLC; Merck & Co., Inc.; and Seattle Genetics, Inc.
Consultant and/or Advisor for Amgen Inc.; AstraZeneca; Bayer Corporation; Dendreon Pharmaceuticals LLC; EMD Serono, Inc.; Incyte Corporation; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and TOLMAR Pharmaceuticals, Inc.

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Providership, Credit, and Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6325-19-T.

Providership


This CME activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by educational grants from Astellas and Medivation, Inc., a Pfizer Company, Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Sanofi Genzyme.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and Penn State College of Medicine are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Penn State College of Medicine.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.